• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (2): 178-184.DOI: 10.3969/j.issn.1671-2587.2026.02.005

• 临床输血 • 上一篇    下一篇

血小板抗体检测临床应用情况分析

施艺璇, 何苏英   

  1. 南方医科大学珠江医院输血医学科,广东广州 510282
  • 收稿日期:2025-05-27 接受日期:2025-08-19 出版日期:2026-04-20 发布日期:2026-04-22
  • 通讯作者: 何苏英,主要从事临床输血研究,(E-mail)1800243032@email.szu.edu.cn。
  • 作者简介:施艺璇,主要从事临床输血研究,(E-mail)syx838@qq.com。

Clinical Application of Platelet Antibody Detection

SHI Yixuan, HE Suying   

  1. Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510282
  • Received:2025-05-27 Accepted:2025-08-19 Online:2026-04-20 Published:2026-04-22

摘要: 目的 探讨血小板抗体的产生、人群分布、与原发疾病和检验指标等因素的关联性及对检测的影响,指导实施精准血小板抗体检测和有效血小板输注。方法 选取2023年3月—2025年4月在南方医科大学珠江医院进行血小板抗体检测的患者29 782例,采用固相凝集法技术检测血小板抗体,分析血小板抗体的产生、人群分布、疾病谱和检验指标等关系。结果 29 782例住院患者中,男性15 353例,女性14 429例,总阳性率2.90%。女性阳性率高于男性(3.37%>2.46%)(P<0.05);女性有妊娠史者血小板抗体阳性率高于无妊娠史者(3.39%>3.07%)(P<0.05);有输血史者阳性率高于无输血史者(4.91%>2.40%),差异具有统计学意义(P<0.05)。不同疾病种类间血小板抗体阳性率差异显著,其中免疫系统性疾病阳性率最高,血液系统性疾病住院患者血小板检测阳性率其次,产科妊娠住院者居第三,差异有统计学意义(P<0.05)。不同妊娠并发症类型与血小板抗体阳性的分布存在整体差异(P<0.05)。血小板抗体阳性者的PLT、WBC、Hct、PT的结果值与阴性者有明显差异,有统计学意义(P<0.05)。女性、妊娠史(女性)、有输血史、低PLT数值、低Hct数值为血小板抗体阳性的独立危险因素(P<0.05)。结论 有输血史、妊娠史、女性患者的血小板抗体阳性率相对较高;免疫性疾病、血液病的血小板抗体阳性率较其他疾病高;有妊娠并发症阳性率较高;血小板抗体阳性与性别、妊娠史、输血史、PLT、Hct密切相关,与WBC、PT具有关联性,可更精准地识别高风险人群,优化输血策略。

关键词: 血小板抗体, 输血, 输血史, 妊娠史, 检验指标

Abstract: Objective To elucidate the mechanisms of platelet antibody production, analyze their distribution across diverse populations, investigate associations with primary diseases and laboratory parameters, and assess their impact on test outcomes—with the ultimate goal of providing evidence-based recommendations for optimizing platelet antibody detection protocols and transfusion strategies. Methods A total of 29 782 patients were enrolled in this study, who had undergone platelet antibody testing at Zhujiang Hospital of Southern Medical University between March 2023 and April 2025. Platelet antibodies were detected using the solid-phase agglutination assay. We analyzed the relationships between platelet antibody production, demographic distribution, disease spectrum, and relevant laboratory indicators. Results Among the 29 782 hospitalized patients (15 353 males and 14 429 females), 864 cases tested positive for platelet antibodies, resulting in an overall positivity rate of 2.90%. Notably, the positivity rate was significantly higher in females than in males (3.37% vs. 2.46%, P<0.05). Females with a history of pregnancy had a higher positivity rate than those without (3.39% vs. 3.07%, P<0.05). Patients with a history of blood transfusions exhibited a higher positivity rate than those without (4.91% vs. 2.40%, P<0.05). Significant differences in positivity rates were observed across disease categories: immune system diseases had the highest rate, followed by hematologic diseases, with obstetric conditions ranking third (P<0.05). The distribution of different types of pregnancy complications also varied significantly with platelet antibody positivity (P<0.05). The results of total white blood cell (WBC) count, platelet (PLT) count, prothrombin time (PT) and hematocrit (Hct) in patients with positive platelet antibody were significantly different from those in negative patients (P<0.05). Female sex, history of pregnancy (in females), history of blood transfusion, low PLT, and low Hct were identified as independent risk factors for platelet antibody positivity. Conclusion Patients with a history of blood transfusion, pregnancy (particularly females), and female patients showed a relatively higher platelet antibody positivity rate. Immune system disorders and hematologic diseases demonstrated markedly higher platelet antibody positivity rates compared to other disease categories. Positivity rates also increased in patients with pregnancy complications. Platelet antibody positivity was closely associated with sex, pregnancy history, transfusion history, PLT and Hct, while also showing some correlation with WBC and PT.These findings enable more precise identification of high-risk populations and optimization of transfusion strategies.

Key words: Platelet antibody, Blood transfusion, Transfusion history, Obstetric history, Laboratory indicators

中图分类号: